about
Integrating Data From the UK National Reporting and Learning System With Work Domain Analysis to Understand Patient Safety Incidents in Community Pharmacy.Medication safety in community pharmacy: a qualitative study of the sociotechnical context.Exploring safety systems for dispensing in community pharmacies: focusing on how staff relate to organizational componentsUnderstanding the implementation and adoption of a technological intervention to improve medication safety in primary care: a realist evaluationWhen procedures meet practice in community pharmacies: qualitative insights from pharmacists and pharmacy support staff.Preventing Acute Kidney Injury: a qualitative study exploring 'sick day rules' implementation in primary carePharmacist work stress and learning from quality related events.What is involved in medicines management across care boundaries? A qualitative study of healthcare practitioners' experiences in the case of acute kidney injuryUnderstanding the implementation and adoption of an information technology intervention to support medicine optimisation in primary care: qualitative study using strong structuration theory.Career breaks and changes of sector: challenges for the revalidation of pharmacists.Psychosocial influences on safety climate: evidence from community pharmacies.Job characteristics, well-being and risky behaviour amongst pharmacists.Human factors in anaesthetic practice: insights from a task analysis.Examining the attitudes of hospital pharmacists to reporting medication safety incidents using the theory of planned behaviour.Pharmacists subjected to disciplinary action: characteristics and risk factors.Job characteristics and safety climate: the role of effort-reward and demand-control-support models.Understanding the attitudes of hospital pharmacists to reporting medication incidents: a qualitative study.Motivational influences on anaesthetists' use of practice guidelines.Determinants of intention to deviate from clinical practice guidelines.Extending hierarchical task analysis to identify cognitive demands and information design requirements.Evaluation of the Pharmacy Safety Climate Questionnaire in European community pharmacies.Understanding procedural violations using Safety-I and Safety-II: The case of community pharmacies.Mindful organizing in patients' contributions to primary care medication safetyDeveloping a learning health system: Insights from a qualitative process evaluation of a pharmacist-led electronic audit and feedback intervention to improve medication safety in primary careOrganizational conditions for engagement in quality and safety improvement: a longitudinal qualitative study of community pharmaciesExploring the human factors of prescribing errors in paediatric intensive care unitsPrevalence, severity, and nature of preventable patient harm across medical care settings: systematic review and meta-analysisMapping the territory of renal care: a formative analysis of the cognitive work involved in managing acute kidney injuryCapturing Patients' Perspectives on Medication Safety: The Development of a Patient-Centered Medication Safety Framework
P50
Q30768156-547FD4B2-BD02-48E4-AF36-0A75F1BE557AQ33500661-7A6F53C5-9B89-4D8B-B3CA-50EA4792D709Q35090626-6D345403-DF1E-450D-8476-C281CF6DF5F1Q36306786-31AE05A7-5FF5-43B1-96A1-F3A74733E5A8Q37007111-96D011D5-91DF-48F4-BE77-A8A3D3DB8915Q37118253-BC1A847C-FF5E-4424-9C13-E1A30CD52E83Q37253294-0B3D2635-5883-4ACE-BFD2-F6BFCD83CA95Q37598195-A604AD5B-9025-4172-8CAC-9216F8126969Q38370844-97029B27-70EC-4978-B7FE-5552E4062E1DQ39541228-2F3939F9-A51B-4B90-9726-C88D25A0C024Q39732117-303B438E-A2BA-4541-BA51-4C49B376D2B8Q40086011-6A5FB2DF-140F-4CB6-9344-88DAD6131885Q40128544-1F9194EF-9526-4302-9DF0-85E465E3D550Q40769313-7842656C-C23F-4553-A3E0-B2C6C5415572Q43816414-F754D4C1-7FF4-4973-9C3D-6BDB1739D79EQ44424937-14637A2D-A743-4020-81F0-AB145C9945EEQ45776061-9572BA39-B2B7-4CD4-A430-7ED7FDB5D58DQ46080368-3D0EAB3A-43A4-41C8-8AF0-2C20BD7C5564Q48226029-10492548-8C89-4F26-BEF4-750DB5A82DC7Q48303908-9741075C-DED7-41D6-A94F-EA29EAB8F316Q51846598-017B1B54-0C0E-4A37-BC5A-69CDCD66A4D0Q54943932-CBDF5F85-AB3D-45F6-A6C3-C183B2DBE741Q57719623-00E96774-DDDC-4743-98E1-956E556820BEQ58549679-9FF4EE0A-E8E4-4709-BD7A-1B414B85270CQ58605192-BEF2F4FC-E433-490F-979D-D8BA923B28D7Q91428822-778DFDA7-948F-4FA8-98BD-90E2195872E5Q91966106-C791D4E8-5E55-4A05-B9C3-0741745B7E38Q92183415-CA8D12FC-F629-49C6-9F1E-994C25DE9672Q92437487-9ECBA8B2-AC3E-4F7E-A769-D375134A2161
P50
description
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Denham L Phipps
@nl
Denham L Phipps
@sl
Denham L. Phipps
@en
Denham L. Phipps
@es
type
label
Denham L Phipps
@nl
Denham L Phipps
@sl
Denham L. Phipps
@en
Denham L. Phipps
@es
prefLabel
Denham L Phipps
@nl
Denham L Phipps
@sl
Denham L. Phipps
@en
Denham L. Phipps
@es
P106
P1153
23980771800
P31
P496
0000-0003-0857-2890